(Q46515927)

22 December 2017

title

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis (English)

1 reference

22 December 2017

1 reference

1 reference

Rajesh Pandey

1

1 reference

22 December 2017

G K Khuller

series ordinal

2

1 reference

22 December 2017

publication date

1 July 2005

1 reference

22 December 2017

published in

Tuberculosis

1 reference

22 December 2017

volume

85

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

227-234

1 reference

22 December 2017

Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Stable biocompatible adjuvants--a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Effect of colloidal carriers on ascorbyl palmitate stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Enhanced liver targeting by synthesis of N1-stearyl-5-Fu and incorporation into solid lipid nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Nebulization of liposome encapsulated antitubercular drugs in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Aerosolised liposomal hamycin for treatment of systemic Candida infections in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Airways delivery of rifampicin microparticles for the treatment of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.11.003

10.1016/J.TUBE.2004.11.003

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017